Wound Management

Avery Dennison Medical Solutions has announced that it has received 510(k) clearance from the U.S. FDA for its new Chlorhexidine Gluconate (CHG) transparent film dressing, known as BeneHold™ CHG Transparent Film Dressing.

The first clinical trial resulting from NICE medical technology guidance recommendations is due to start soon on a device to promote wound healing.

Covalon Announces FDA Clearance for SurgiClear™ Antimicrobial Silicone Wound Dressing (via PR Newswire) MISSISSAUGA, ON, Aug. 21, 2012 /PRNewswire/ – … continue reading “Covalon Announces FDA Clearance For SurgiClear™ Antimicrobial Silicone Wound Dressing”

MiMedx Group Inc., manufactures Epifix®, a wound treatment based on processed Human Amniotic Membrane. In a prospective randomised controlled study it appears the product significantly improves the healing rate of diabetic foot ulcers compared with standard of care only, to the extent that the trial was terminated early.

Financial key performance indicators for S&N’s quarter, when set against the equivalent period a year ago show revenue of $1,029 million, up 2% on an underlying basis, trading profit of $234 million, up 6% on an underlying basis, with trading profit margin up 80 bps to 22.7% as Advanced Surgical Devices (ASD) division restructuring benefits come through

EquinoxO2 Medical, developer of negative pressure wound therapy foam dressings and pump systems, has announced introduction and distribution of its HALO XP npwt pump system.

It’s all a bit weird. Companies issue press releases containing information about their rosy prospects all the time, but they don’t often charge you for the privilege of reading them. Tissue Regeneration Technologies obviously has other ideas.

Kinetic Concepts, Inc. announced today that it has received FDA 510(k) clearance to market its proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System, for the management of closed surgical incisions.

Systagenix is trumpeting the fact that more than 1,000 clinicians from over 400 sites across Europe, the Middle East and South Africa have now been trained in the four months since the launch of WOUNDCHEK™ Protease Status, the world’s first point of care test for Elevated Protease Activity (EPA) in chronic wounds.

Smith & Nephew, Inc. acquires Kalypto Medical, Inc., further investing in Negative Pressure Wound Therapy to deliver continual innovation

Single study shows novel hydrogel scaffold results in better wounds. Product gets CE mark. Should it really be that simple?

If you’re going to the trouble to issue a press release, it really out to be a little more reader-friendly and maybe even contain some useful information. A wound spray to help chronic wounds heal sounds great, but most medical professionals might ask how (and how well) it works before they get too excited that it’s gained CE mark approval.

Can CellSonic make its ESWT offering a world beater in treating troublesome non-healing wounds?

Innovative dressing technology designed to reduce the need for frequent and painful dressing changes in burn patient care.

Smith & Nephew’s 2011 was pretty good according to its financials and the company is getting a handle on its costs, suggesting a strong 2012, albeit at the expense of further job losses.

Systagenix Wound Management has announced that it has gained CE mark status for its WOUNDCHEK™ Protease Status diagnostic tool to aid wound assessment.